Blog - Page 5380 of 5423

TuesdayJul 25, 2006 12:24 pm

StockGuru Blog: IncreMental Advantage Report Optimistic for The Immune Response Corporation

IMNR - The Immune Response Corporation The Immune Response Corporation (IMNR) announced that IncreMental Advantage, an equity research firm, has initiated coverage on the Company with an Accumulate rating, and a price target of $0.09 per share. The Immune Response Corporation’s product pipeline has two clinical stage therapeutics in Phase II development, NeuroVax(TM) for multiple sclerosis (MS), and IR103 for HIV/AIDS. The report was issued by IncreMental’s highly experienced biotechnology analyst, Robert LeBoyer, who has more than 14 years of Wall Street experience. IncreMental Advantage noted in the report that, “The current market capitalization is only $13.1 million. It is…

TuesdayJul 25, 2006 12:21 pm

StockGuru Blog: Elgrande International, Inc. Obtains Debenture Financing from Divine Capital Markets LLC

EGDI – Elgrande International, Inc.Elgrande International (OTCBB: EGDI) specializing in importing, marketing and distributing European-designed quality products has executed an agreement with Divine Capital Markets LLC that provides the Company with upto $US 600,000 in convertible debenture financing. The debentures are due three years from the closing date and are convertible into restricted common stock of the Company. Related to this financing, the Company filed aform 8-K with the Securities and Exchange Commission on January 13, 2006. Divine Capital Markets LLC is a boutique securities brokerage and investment banking firm. The firm is recognized for providing institutions, corporations and a…

TuesdayJul 25, 2006 12:20 pm

StockGuru Blog: Elgrande International Retains the AZS Companies Consulting Group to Develop Growth Strategies

EGDI – Elgrande International, Inc.Elgrande International (OTCBB: EGDI) announced that they have retained The AZS Companies consulting group to assist in developing and implementing strategic growth plans to guide the Company’s corporate development over the coming three years. From the launch of the Company’s wholesale activities in 2003 the Company has seen the North American home décor market embrace its products. Elgrande was the winner of the Canadian Gift and Tableware Association best new product award, featured on Oprah Winfrey’s”O List” and in many national magazines and syndicated TV shows, Elgrande’s current product line has received strong consumer, media and…

TuesdayJul 25, 2006 12:17 pm

StockGuru Morning Alert: Yesterday Elgrande International (OTCBB: EGDI) – Up as much as 30.7%, Closing Up Almost 8% on Heavy Volume

StockGuru Alert: Yesterday… Elgrande International (OTCBB: EGDI) - Up as much as 30.7%, Closing Up Almost 8% on Heavy Volume Elgrande International, Inc. (OTCBB: EGDI) View the StockGuru Profile for Elgrande International (OTCBB: EGDI): http://www.stockguru.com/profiles/egdi/ We Invite you to Visit the All New StockGuru Blog! Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks. Click HERE to visit the Blog, or go to: http://stockguru.com/blog/ StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was…

TuesdayJul 25, 2006 12:14 pm

StockGuru News: Clearly Canadian Beverage Corporation (OTCBB: CCBEF) Significantly Improves Financial Position

Clearly Canadian Beverage Corporation (OTCBB: CCBEF) Clearly Canadian Significantly Improves Financial Position VANCOUVER, B.C.–July 25, 2006–CLEARLY CANADIAN BEVERAGE CORPORATION (OTCBB: CCBEF) is pleased to announce that on the heels of its recent financings and settlement of outstanding litigation, it is now, aside from regular trade payables, effectively debt free and has increased its current cash position to more than US $5.3 million. Brent Lokash, President of Clearly Canadian stated, “We now have a very strong financial foundation which could accelerate our efforts towards broadening distribution, increasing availability of our product lines, exploring all profitable alternatives related to our brand name…

TuesdayJul 25, 2006 12:09 pm

StockGuru News: Transnational Automotive Group and On The Go Technologies Group

Transnational Automotive Group (OTCBB:TAMG) TAMG Buses Arrive in Cameroon SEATTLE, WASHINGTON–(MARKET WIRE)–Jul 25, 2006 — Transnational Automotive Group, Inc. (OTC BB:TAMG.OB - News), today announced that the Company’s first 28 buses, under its Cameroon public transport contract, arrived at the port of Douala on 22 July and were unloaded from the cargo ship BBC Germany. Read full release here: http://stockguru.com/profiles/tamg/news.php On The Go Technologies Group (OTCBB: OGHC) On The Go Appoints GE IT Solutions and CompuCom Systems Veteran as Enterprise Division Sales Director CONCORD, Ontario, July 25 /PRNewswire-FirstCall/ — On The Go Technologies Group (OTC Bulletin Board: OGHC - News),…

TuesdayJul 25, 2006 11:58 am

StockGuru News: Mobile Ready Entertainment Corporation (OTC:MBRN) Closes Acquisition With Key2Travel Inc.

Mobile Ready Entertainment Corporation (OTC:MBRN) Mobile Ready Entertainment Corp. Closes Acquisition With Key2Travel Inc. MBRN Announces Close of Acquisition Transaction With Las Vegas Travel Entertainment Company STROUDSBURG, PA and LAS VEGAS, NV–(MARKET WIRE)–Jul 25, 2006 — Mobile Ready Entertainment Corp. (OTC: MBRN) is pleased to announce that it had signed and closed the definitive acquisition documents with Key2Travel Inc. in a deal that brings product, personnel and a good balance sheet to the Company. “Today represents one of the most significant steps in Mobile Ready’s formation,” said Josh Eikov, CEO of Mobile Ready Entertainment Corp. “Mobile Ready is now on…

MondayJul 24, 2006 11:56 am

StockGuru Blog: The Immune Response Vaccines — Clinical Trials for HIV Infections

IMNR - The Immune Response Corporation Clinical Studies With IR 103 IMNR’s clinical trial program is testing IR103 in drug-naïve HIV-infected individuals with HIV infection who do not meet the criteria for antiretroviral therapy. The objective is to determine if IR103 can delay disease progression and extend the time to starting antiretroviral therapy, mimicking the effect seen in long term non-progressing patients. IR103 is currently in two Phase II clinical trials with identical protocols. The two trials are known as IR111 (Canada/UK) and IR112 (Italy/France). The Phase I/II clinical trials began in 2004. IMNR completed a 49-patient Phase I/II five-arm,…

MondayJul 24, 2006 11:47 am

StockGuru News: IncreMental Advantage Initiates Coverage of The Immune Response Corporation with Price Target of $0.09 Per Share, Accumulate Rating

IncreMental Advantage Initiates Coverage of The Immune Response Corporation with Price Target of $0.09 Per Share, Accumulate Rating The Immune Response Corporation (OTCBB: IMNR) CARLSBAD, Calif.–(BUSINESS WIRE)–July 24, 2006–The Immune Response Corporation (OTCBB: IMNR - News) announced today that IncreMental Advantage, an equity research firm, has initiated coverage on the Company with an Accumulate rating, and a price target of $0.09 per share. The Immune Response Corporation’s product pipeline has two clinical stage therapeutics in Phase II development, NeuroVax(TM) for multiple sclerosis (MS), and IR103 for HIV/AIDS. The report was issued by IncreMental’s highly experienced biotechnology analyst, Robert LeBoyer, who…

MondayJul 24, 2006 11:47 am

StockGuru News: Response Biomedical Corporation, China Wireless Communications, Cavico Corporation, Oxford Media, and Enterayon

Response Biomedical Corp. (OTCBB: RPBIF) & (TSX.V: RBM) Response Biomedical Completes US Distribution Network For RAMP Cardiovascular Products US Distributors include Cardio Medical Products, Kentec Medical, and LXU Healthcare VANCOUVER, July 24 /CNW/ - Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF), announced today that RAMP Cardiac Tests are now commercially available throughout the US through three exclusive regional distributors. Response Biomedical completed its US distribution network with the appointments of two additional exclusive regional US distributors: Kentec Medical, Inc. and Cardio Medical Products, Inc. Read full release here: http://stockguru.com/profiles/rpbif/news.php China Wireless Communications (OTCBB: CWLC) China Wireless Shareholder Update: Company Is…

Site Search

Company Search